Spruce Biosciences
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch SPRB and buy or sell other stocks, ETFs, and their options commission-free!About SPRB
Spruce Biosciences, Inc. is a late-stage biopharmaceutical company, which engages in developing and commercializing novel therapies for rare endocrine disorders with significant unmet medical need. It focuses on developing its wholly owned product candidate, Tildacerfont.
CEOJavier Szwarcberg
CEOJavier Szwarcberg
Employees21
Employees21
HeadquartersSouth San Francisco, California
HeadquartersSouth San Francisco, California
Founded2014
Founded2014
Employees21
Employees21
SPRB Key Statistics
Market cap4.67M
Market cap4.67M
Price-Earnings ratio-0.08
Price-Earnings ratio-0.08
Dividend yield—
Dividend yield—
Average volume383.53K
Average volume383.53K
High today$0.1099
High today$0.1099
Low today$0.0966
Low today$0.0966
Open price$0.101
Open price$0.101
Volume97.85K
Volume97.85K
52 Week high$0.608
52 Week high$0.608
52 Week low$0.057
52 Week low$0.057
People also own
Based on the portfolios of people who own SPRB. This list is generated using Robinhood data, and it’s not a recommendation.